Easy Efficient Molar Endodontics – CDE

Easy Efficient Molar Endodontics – CDE

DentistryUnited Academy is happy to announce 2 days CDE program in Endodontics :

endo

 

Topics :

Diagnosis and Case Selection

Tips on Access Cavity Preparation

Shaping and Cleaning – Hand vs Rotary

Endodontic Irrigation Protocols

Apex Locators

Intracanal Medicaments

Various Rotary Endodontics systems

Obturation Techniques

Problem Solving in Endodontics

 

Faculty : Dr. Shiraz Pasha MDS

 Dates : 14/15 August 2017

Time : 10:30am – 5:00pm

Location : Bangalore

Fee : 18900/-

Fee includes Work-time Lunch/Snacks

For Details call : +91-98451 06626

Register by Transferring Rs. 5000/- online 

A/c :DentistryUnited.com – 0851131001573

IFSC : ORBC0100851

 

 

Align Technology – A business built on patents

Align Technology was founded in 1997 by two Stanford MBA students, Zia Chishti and Kelsey Wirth, who had no background in orthodontics (Chishti had undergraduate degrees in economics and computer science, Wirth in literature and American History). But the pair believed that a clear version of braces would be a huge hit, upending an industry that had been using roughly the same metal brackets-and-wires to straighten teeth for decades. Believers helped them raise $130 million in a 2001 public offering, but much of that money was blown on sales and marketing efforts, including a massive national direct to consumer ad campaign. They spent $52 million that same year but only sold $45 million worth of the aligners.

After years of tepid growth, Align’s Silicon Valley tech is winning over more customers in the slow-changing orthodontics business, boosting company sales 28% year-over-year. It has an estimated 80% of the North America “clear aligner” orthodontics market, and is offered by more than 50,000 orthodontists and dentists. Invisalign hit its 4 millionth patient in September. In 2016, sales hit $1 billion for the first time. The stock is up 62% in the last 12 months, well outpacing the S&P 500, which is up 13% in the same time. Its success is due to its near monopoly on clear braces, but also its patented processes that digitally map and build out a patient’s treatment.

Now the company is reaching a crossroads and some wonder if it can continue to deliver such sparkling returns. On the one hand, there are still plenty of teeth for it to straighten. Last year Invisalign products were used in roughly 8% of the 3 million new orthodontic patients in North America. On the other hand, one of its biggest advantages – its arsenal of more than 400 U.S. and 300 foreign-issued patents covering everything from the type of plastic that’s worn in patients’ mouths to the software orthodontists use to plan out teeth movements millimeter-by-millimeter, months in advance – is facing its term limits.